A detailed history of Frazier Financial Advisors, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Frazier Financial Advisors, LLC holds 565 shares of LLY stock, worth $484,470. This represents 0.36% of its overall portfolio holdings.

Number of Shares
565
Previous 410 37.8%
Holding current value
$484,470
Previous $239 Million 83.98%
% of portfolio
0.36%
Previous 0.21%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

BUY
$592.2 - $792.28 $91,791 - $122,803
155 Added 37.8%
565 $439 Million
Q4 2023

Feb 09, 2024

BUY
$525.19 - $619.13 $215,327 - $253,843
410 New
410 $239 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $815B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Frazier Financial Advisors, LLC Portfolio

Follow Frazier Financial Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Frazier Financial Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Frazier Financial Advisors, LLC with notifications on news.